Chief Executive Officer of Hevolution Foundation, Kingdom of Saudi Arabia.

 Khan is a member of the Board of Directors of Reckitt Benckiser and of the Saudi Research,
Development, and Innovation Authority "RDIA", a member of the Saudi National Biotechnology Strategy
Steering Committee, and Steering Committee.

He served as the Chairman of the Visiting Committee on Advanced Technology of the United States’ National Institute of Standards and Technology "NIST", and Executive Chairman of Life Biosciences in the United States.

Mehmood Khan’s career has included several senior corporate roles, including Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, and President of Global R&D at Takeda Pharmaceuticals.

Before moving into the private sector Mehmood was a faculty member in endocrinology at the Mayo Clinic and Medical School, where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also led programs in diabetes, endocrinology, metabolism, and nutrition in Minneapolis.

Khan earned his medical degree from the University of Liverpool School of Medicine, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis.

He is a Fellow of the Royal College of Physicians in London, a Fellow of the American College of Endocrinology, and an Elected Fellow in the Department of Pharmacology at University of Oxford.